METHODS
SBRT treatment was planned for 10 patients with liver cancer using 1-mm and 2.5-mm CGS with AAA
and AXB algorithms with 10 MV flattening filter-free (FFF) rays in Varian Trubeam STx.
RESULTS
When AAA 1-mm CGS plans and AAA 2.5-mm CGS plans were compared, 4% difference was observed;
when AXB 1-mm CGS plans and AXB 2.5-mm CGS plans were compared, 1% difference was
found. No significant difference was found between plans with AAA 1-mm CGS and plans with AXB
1-mm CGS (p>0.05). On the other hand, there was a significant difference between plans with AAA 2.5-
mm CGS and plans with AXB 2.5-mm CGS (p<0.05).
CONCLUSION
As a result of the study, it was seen that the AXB algorithm gave more stable results than the AAA one
in different intensity body regions. High doses are administered in a small number of fractions in SBRT.
For SBRT, 1-mm CGS should be selected for calculation accuracy.
Keywords: Anisotropic analytical algorithm; acuros XB; calculation grid size
In the treatment planning system of Eclipse 13.0 (Varian Medical Systems, Palo Alto, CA), the anisotropic analytical algorithm (AAA) is commonly used for dose calculation.
Recently, in the dosimetric study performed by
many investigators, it has been reported that AAA calculated
the calculated dose significantly inaccurate.[
There are many studies in the literature that dosimetrically
compared the AAA and AXB algorithms.[
The dose difference between the two algorithms results
from parameters such as energy of the incoming beam,
field size, and electron density of the medium.
However, studies have reported that the calculation
grid size (CGS) is associated with dose changes. The
difference between AAA and AXB due to different uses
is not known to affect SBRT treatments, and this effect
requires further investigation.
The dosimetric effect of AXB in the SBRT plan for
lung cancer has little information on this. With advancing
technological facilities, manufacturers of linear
accelerator devices offer both flattened (FF) and
unflattened (FFF) beams together. SBRT treatments
can be applied to patients in a shorter time because of
increased dose rate due to FFF beams.
This study aimed to investigate the calculated differences
between AXB and AAA and the dose-related
effect of dose CGS on SBRT treatments for planned
liver cancer with FFF beams.
Analytical Anisotropic Algorithm
Acuros XB Algorithm
Instead of Boltzman Transport Equation, which describes
the macroscopic behavior of radiation particles,
LBTE, its linear form, assumes that the particles in the
environment interact with each other and the external
magnetic field.[
Monte Carlo and LBTE solution methods produce
close results but fail to produce clear solutions.[
The source model of the AXB algorithm used in the
Eclipse TPS uses the existing AAA source model. In
this model; primary photons, out-of-focus photons,
contaminant electrons, and photons scattered from the
wedge.
The AXB algorithm uses knowledge of the mass
concentration obtained in the CT images of each voxel
for dose calculation. The calculation difference between
the AAA and AXB algorithms depends on the
beam energy, field size, and material density.
Varian TrueBeam STx Linear Accelerators
TrueBeam STx linear accelerator has a multileaf
(MLC) consisting of 120 tungsten materials. MLCs are
2.5 mm thick in the isocenter and have 32 pairs of MLC
and 28 pairs of 5-mm MLC that surround them from
the outside. The tongue-and-groove effect has the same
design as the Millennium MLC and the High Definition
MLC (HD-MLC) in terms of rounded leaf edge
properties. The radius of curvature of the Millennium
120 MLC is 8 cm, while the radius of curvature of HDMLC
is 16 cm. HD-MLC, irregularly shaped areas of 40
cm wide and 22 cm long can be formed.
We recruited 10 patients with liver cancer who
were referred to our clinic and their CT data was used.
Treatment plans were generated using the volumetric modulated arc (VMAT) SBRT planning method have
been used two partial Arc angles with 10 MV FFF
beams of Varian TrueBeam STx. For each patient, four
treatment planning were done using AAA and AXB algorithms
using 1 and 2.5 mm calculation grid (CGS),
respectively.
The AAA dose calculation model is a 3D pencil beam
and convolution superposition algorithm consisting
of separate models for electrons emitted from primary
photons, scattered photons, and beam modulators
(primary collimator, beam straightening filter, and
wedge filter).[
The AXB algorithm was developed for two strategic
needs such as accuracy and speed in external photon
beam treatment planning. AXB uses a sophisticated
technique to solve the LBTE and fully exploits heterogeneity
in patient mortality from lung, bone, air, and
non-biological implants.
Varian TrueBeam STx is a radiotherapy device using
3D Conformal, IMRT, IGRT, VMAT, stereotactic radiosurgery
(SRS), and stereotactic body radiotherapy
(SBRT). This linear accelerator is designed as a digital
linear accelerator with 6 MV, 10 MV, 15 MV flattening
filters (FF) and 6 MV and 10 MV flattening filter-free
(FFF) beams. The dose range of filtered beams is 100-
600 MU/min, 400-1400 MU/min for unfiltered FFF
beams is 6 MV, and 400-2400 MU/min for 10 MV FFF.
The maximum area dimensions used for active MLC
with minimum 0.5×0.5 cm and maximum 40×40 cm
area dimensions are 22×40 cm.
Figures
In the case of spinal cord, the AXB algorithm predicted a higher dose than the AAA algorithm. The dose change on the spinal cord was statistically significant (p<0.05). However, the ipsilateral lung V5 and V10 are statistically higher in the AAA algorithm than in the AXB algorithm.
There was a significant difference between PTV minimum doses of 1 mm CGS and 2.5 mm CGS AAA (p<0.05), whereas AXB plan with 1 mm CGS and AXB plans with 2.5 mm CGS showed close results (p>0.05). Considering the Dmax and Dmean doses for the heart, AAA and AXB with 1 and 2.5 mm CGS were not significantly associated with all plans (p>0.05). This is due to the fact that the AXB algorithm does not provide enough information about out-of-field side doses.
In the case of Dmean doses of ipsilateral lung doses, there was a significant difference between AAA plans with 1 mm CGS and 2.5 mm CGS (p<0.05). Likewise, differences between AXB plans with 2.5 mm CGS were significant (p<0.05). No significant results were found between AAA with 1 mm CGS and AXB plans with 1 mm CGS (p>0.05).
There was a significant difference between bilateral renal doses of 1-mm CGS AAA and AXB plans and 2.5-mm CGS AAA and AXB (p<0.05).
When we examined the small intestinal Dmax doses in our study, no significant difference was found between 1-mm CGS plans and 2.5-mm CGS plans (p>0.05). The most interesting aspect of the work is that there is a 1% difference between AAA plans with 2.5-mm CGS and AXB plans with 2.5-mm CGS, and 5% difference between AAA plans with 1-mm CGS and AXB plans with 1-mm CGS.
In their study, Kan et al.[
The difference between AAA and AXB is interesting
as CGS has also contributed to the correct dose
calculation. CGS is associated with the estimate and
calculation accuracy. Kan et al.[
In addition, Kan et al.[
Chung et al.[
In our study, we found that there were 4% difference
between AAA 1-mm CGS plans and AAA 2.5-mm
CGS plans, whereas AXB 1-mm CGS plans and AXB
2.5-mm CGS plans had 1% difference.
Regarding the PTV minimum doses, it was seen
that there was a 5% difference between AAA plans with
1-mm CGS and AXB plans with 1-mm CGS. This may
be the reason for the preference of the AXB algorithm
to reduce the PTV dose during treatment planning.
The effect of the dose difference between the two algorithms
will be another area of interest for us. Our other
work will focus on the difference between the two algorithms
for different energy stages, focusing on the lung
SBRT where small areas and air spaces are located.
In conclusion, SBRT treatments administer high
doses in a small number of fractions. The accuracy of
calculation related the accuracy of these treatments; it
is necessary to ensure the dose response in the critical
regions of the algorithm used.[
Disclosure Statement
Ethics Committee Approval: This study was conducted inaccordance
with local ethical rules.
Peer-review: Externally peer-reviewed.
Conflict of Interest: None declared.
The authors declare no conflicts of interest.